Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine Contracts + Grants October 15, 2012 …
NIH Awards $1.8M to Develop Multi-Component Malaria Vaccine Solution Industry News October 13, 2012 …
AstraZeneca and Broad Institute Partner To Advance Antibacterials and Antivirals Antimicrobial Resistance September 17, 2012 …
FDA Grants Priority Review for Multi-Drug Resistant Tuberculosis Treatment Medical Countermeasures September 6, 2012 …
